Adma Biologics (ADMA) Asset Utilization Ratio (2012 - 2025)

Adma Biologics' Asset Utilization Ratio history runs 12 years deep, the most recent figure standing at 0.86 for Q4 2025.

• Quarterly Asset Utilization Ratio fell 11.82% year-over-year to 0.86 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.86 (down 11.82% YoY) and the FY2025 annual result came in at 0.92, down 12.09% from the prior year.
• Asset Utilization Ratio was 0.86 for Q4 2025 at Adma Biologics, down from 0.87 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.03 in Q2 2024 and bottomed at 0.22 in Q1 2021.
• A 5-year average of 0.69 and a median of 0.74 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2021 — Asset Utilization Ratio plunged 32.25% — and 2022, when it soared 139.58%.
• Adma Biologics' Asset Utilization Ratio stood at 0.43 in 2021, then soared by 41.33% to 0.6 in 2022, then soared by 47.56% to 0.89 in 2023, then rose by 9.29% to 0.97 in 2024, then declined by 11.82% to 0.86 in 2025.
• Business Quant data shows ADMA's Asset Utilization Ratio at 0.86 in Q4 2025, 0.87 in Q3 2025, and 0.89 in Q2 2025.